Iradimed Corp
IRMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001325618
In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Iradimed Corp changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 139 | 1 | 145 | +7 |
| Shares | 6.82M | 818.3K | 6.77M | +771.1K (+12.8%) |
| Value | $299.8M | $36.0M | $340.3M | +$76.5M (+29.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Iradimed Corp at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 939,737 | $47.3M | 0.00% |
| Oak Ridge Investments LLC | 43,499 | $2.19M | 0.19% |
| Eagle Asset Management Inc | 24,632 | $1.39M | 0.01% |
| Globeflex Capital L P | 15,546 | $781.8K | 0.07% |
| Albert D Mason Inc | 14,659 | $737.2K | 0.47% |
| Granahan Investment Management Inc | 10,521 | $529.1K | 0.02% |
| Walleye Capital LLC | 7,177 | $360.9K | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 7,137 | $358.9K | 0.01% |
| Semanteon Capital Management, LP | 6,576 | $330.7K | 0.23% |
| Options Solutions, LLC | 5,410 | $272.1K | 0.13% |
| Calamos Advisors LLC | 5,031 | $253.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,970 | $249.9K | 0.00% |
| Principal Financial Group Inc | 4,894 | $246.1K | 0.00% |
| SG Americas Securities, LLC | 2,931 | $147.0K | 0.00% |
| Bryn Mawr Trust Co | 2,500 | $125.7K | 0.00% |
| NBC Securities, Inc. | 365 | $18.0K | 0.00% |
| Harbor Capital Advisors, Inc. | 118 | $6.00K | 0.00% |
| Capital Performance Advisors LLP | 25 | $1.26K | 0.00% |
| Geneos Wealth Management Inc. | 22 | $1.11K | 0.00% |
| Larson Financial Group LLC | 15 | $754 | 0.00% |
| Sterling Capital Management LLC | 7 | $352 | 0.00% |
| Signaturefd, LLC | 7 | $352 | 0.00% |
Sold out (15)
Institutions that held Iradimed Corp at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Bares Capital Management, Inc. | 283,600 | $12.5M |
| RK Capital Management, LLC | 170,084 | $7.47M |
| Soleus Capital Management, L.P. | 102,067 | $4.48M |
| Citadel Advisors LLC | 17,750 | $779.9K |
| Norges Bank | 16,500 | $725.0K |
| Sequoia Financial Advisors, LLC | 12,918 | $567.6K |
| LSV Asset Management | 12,600 | $554.0K |
| Marshall Wace, LLP | 10,531 | $462.7K |
| Y-Intercept (Hong Kong) Ltd | 9,535 | $419.0K |
| Invesco Ltd. | 7,081 | $311.1K |
| XTX Topco Ltd | 6,036 | $265.2K |
| Bailard, Inc. | 4,600 | $202.1K |
| nVerses Capital, LLC | 400 | $17.6K |
| Cornerstone Planning Group LLC | 15 | $664 |
| Innealta Capital, LLC | 12 | $527 |
Not filed for Q3 2024 yet (1)
Institutions that held Iradimed Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 818,343 | $36.0M |